Open Access Open Access  Restricted Access Subscription Access

An Essential Parameters of Influenza Virus Include Patho Physiology, Histo Pathology, Diagnosis, Differential Diagnosis and Treatment

Srinivas G., Ramanjaneyulu D.V., D Satyanarayana Murthy, Muralinath E., Guruprasad M., Sravani Pragna K., Manjari P., Sony Sharlet E., T. Nikhil, V. Yaswanth Sai, D. Kusuma Latha, Ch. Ramya Sudha, K. Sridevi, D. Gokul Shiva Balaji

Abstract


Influenza affects both the upper and lower respiratory tracts and is a contagious viral illness. It is caused by many different types of influenza viruses. Certain viruses are especially species-specific, and some of them can infect humans. The pathophysiology, histopathology, diagnosis, differential diagnosis, and therapy of influenza are all covered in this exercise.


Full Text:

PDF

References


Alguacil-Ramos, A. M., Portero-Alonso, A., Pastor-Villalba, E., Muelas-Tirado, J., Díez-Domingo, J., Sanchis-Ferrer, A., & Lluch-Rodrigo, J. A. (2019). Rapid assessment of enhanced safety surveillance for influenza vaccine. Public Health, 168, 137–141.

Tennant, R. K., Holzer, B., Love, J., Tchilian, E., & White, H. N. (2019). Higher levels of B-cell mutation in the early germinal centres of an inefficient secondary antibody response to a variant influenza haemagglutinin. Immunology, 157(1), 86–91.

Marshall, C., Williams, K., Matchett, E., & Hobbs, L. (2019). Sustained improvement in staff influenza vaccination rates over six years without a mandatory policy. Infection Control & Hospital Epidemiology, 40(3), 389–390.

Odun-Ayo, F., Odaibo, G., & Olaleye, D. (2018). Influenza virus A (H1 and H3) and B co-circulation among patients presenting with acute respiratory tract infection in Ibadan, Nigeria. African Health Sciences, 18(4), 1134–1143.

Havlíčková, M., Druelles, S., Jirincová, H., Limberková, R., Nagy, A., Rasuli, A., & Kynčl, J. (2019). Circulation of influenza A and B in the Czech Republic from 2000–2001 to 2015–2016. BMC Infectious Diseases, 19(1), 160. https://doi.org/10.1186/s12879-019-3780-5

Yang, L., Chan, K. P., Wong, C. M., Chiu, S. S. S., Magalhães, R. J. S., Thach, T. Q., Peiris, J. S. M., Clements, A. C. A., & Hu, W. (2019). Comparison of influenza disease burden in older populations of Hong Kong and Brisbane: The impact of influenza and pneumococcal vaccination. BMC Infectious Diseases, 19(1), 162. https://doi.org/10.1186/s12879-019-3782-3

Blanton, L., Dugan, V. G., Abd Elal, A. I., Alabi, N., Barnes, J., Brammer, L., Budd, A. P., Burns, E., Cummings, C. N., Garg, S., Garten, R., Gubareva, L., Kniss, K., Kramer, N., O’Halloran, A., Reed, C., Rolfes, M., Sessions, W., Taylor, C., Xu, X., Fry, A. M., Wentworth, D. E., Katz, J., & Jernigan, D. (2019). Update: Influenza activity—United States, September 30, 2018–February 2, 2019. Morbidity and Mortality Weekly Report, 68(6), 125–134.

Haber, P., Moro, P. L., Ng, C., Dores, G. M., Lewis, P., & Cano, M. (2019). Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016–June 2018. Vaccine, 37(11), 1516–1520.

Kenmoe, S., Tcharnenwa, C., Monamele, G. C., Kengne, C. N., Ripa, M. N., Whitaker, B., Alroy, K. A., Balajee, S. A., & Njouom, R. (2019). Comparison of FTD® respiratory pathogens 33 and a singleplex CDC assay for the detection of respiratory viruses: A study from Cameroon. Diagnostic Microbiology and Infectious Disease, 94(3), 236–242.

Doyle, J. D., Chung, J. R., Kim, S. S., Gaglani, M., Raiyani, C., Zimmerman, R. K., Nowalk, M. P., Jackson, M. L., Jackson, L. A., Monto, A. S., Martin, E. T., Belongia, E. A., McLean, H. Q., Foust, A., Sessions, W., Berman, L., Garten, R. J., Barnes, J. R., Wentworth, D. E., Fry, A. M., Patel, M. M., & Flannery, B. (2019). Interim estimates of 2018–19 seasonal influenza vaccine effectiveness—United States, February 2019. Morbidity and Mortality Weekly Report, 68(6), 135–139.


Refbacks

  • There are currently no refbacks.